U.S. Metals and Mining Stock News

Hayward Holdings (HAYW) drew fresh attention after reporting first quarter results, with sales of US$255.22 million and net income of US$23.36 million, alongside higher full year 2026 sales and earnings guidance. See our latest analysis for Hayward Holdings. Despite the stronger first quarter and higher 2026 guidance, Hayward Holdings’ 1-day and 7-day share price returns of 1.01% and 1.60% contrast with a 9.08% 1-month gain, while 1-year and 3-year total shareholder returns of 5.12% and...

Recent performance snapshot for Vita Coco Company (COCO) With no single headline event driving attention to Vita Coco Company (COCO), recent performance is drawing interest. The stock shows a 0.6% decline over the past day but a 3.4% gain over the past week. Investors are also watching its longer streak, with the share price showing a roughly 39% move over the past month and about 16% over the past 3 months, set against year to date and 1 year total returns. See our latest analysis for Vita...

If you are wondering whether Cintas is attractively priced or trading on too rich a premium, starting with a clear look at its current valuation can help you frame that decision. The stock last closed at US$170.04, with returns of a 2.7% decline over 7 days, a 0.1% decline over 30 days, an 8.0% decline year to date, a 20.2% decline over 1 year, 47.2% over 3 years and 101.2% over 5 years, which may shape how you think about both risk and opportunity. Recent news around Cintas has focused on...

Recent analyst commentary around Copa Holdings (CPA) has focused on expectations for higher revenues and a possible earnings beat in the March 2026 quarter, with the upcoming May 13 report drawing closer attention. See our latest analysis for Copa Holdings. Copa Holdings' share price has recently picked up, with a 7 day share price return of 6.24% and a 30 day share price return of 10.16%. This comes even though the 90 day share price return is a 20.24% decline, while the 1 year total...

Ingles Markets, Incorporated recently reported past second-quarter 2026 results showing sales of US$1,307.86 million and net income of US$24.27 million, alongside stronger first-half earnings versus the prior year. These financial results arrived just after activist investor Summer Road LLC secured board representation through the election of its nominee Rory A. Held, sharpening attention on Ingles’ governance and use of its real estate assets. We will now examine how the combination of...

In early May 2026, Allient Inc. reported first-quarter 2026 results showing sales of US$138.92 million and net income of US$5.36 million, alongside a quarterly dividend of US$0.04 per share payable on June 4, 2026. Despite year-over-year growth in revenue and earnings per share, Allient’s first-quarter adjusted profit margins fell short of analyst expectations, highlighting tension between top-line momentum and cost pressures. With earnings growing but margins missing consensus, we’ll now...

Trex Company (TREX) is back in focus after recent share price moves, with the stock closing at US$39.19. Investors are weighing this level against the company’s earnings profile and current valuation signals. See our latest analysis for Trex Company. Recent trading has been choppy, with a 10.55% 1 month share price return contrasting with a 10.93% 3 month share price decline and a 32.78% 1 year total shareholder return loss. This suggests momentum has been fading even as investors reassess...

Event context and recent stock performance Tarsus Pharmaceuticals (TARS) has attracted investor attention recently as its share price has moved over the past month and past 3 months, with the stock last closing at US$63.96 and a market value of about US$2.8b. See our latest analysis for Tarsus Pharmaceuticals. Zooming out, the stock’s recent share price returns, including a 6.98% 1 month decline and a 20.81% year to date decline, contrast with a 35.68% 1 year total shareholder return and very...

Enovis Corporation recently reported first-quarter 2026 results, with sales rising to US$589.15 million from US$558.83 million a year earlier and net loss narrowing to US$8.76 million from US$55.97 million, while basic and diluted loss per share from continuing operations improved to US$0.15 from US$0.98. The company also reaffirmed its full-year 2026 revenue guidance of about US$2.31 billion to US$2.37 billion, highlighting confidence in growth from its Reconstructive segment and new...

IDACORP, Inc. reported past first-quarter 2026 results showing sales of US$402.76 million and net income of US$67.98 million, with diluted EPS from continuing operations of US$1.21, up from US$1.10 a year earlier. Alongside reaffirming its full-year 2026 earnings guidance of US$6.25 to US$6.45 per diluted share, the company expects Idaho Power to use less than US$30 million of additional tax credits under its Idaho regulatory mechanism, assuming normal weather and power supply expenses. We...

Why Ivanhoe Electric’s latest quarter is on investor radar Ivanhoe Electric (IE) returned to profitability in the first quarter of 2026, reporting net income of US$41.74 million compared with a net loss a year earlier, a shift that has drawn fresh attention to the stock. See our latest analysis for Ivanhoe Electric. The return to profit has arrived after a volatile period, with a 16.17% 1 month share price return and a 113.04% 1 year total shareholder return contrasting with weaker year to...

In 2025, VinFast Auto more than doubled its electric vehicle deliveries to 196,919 units and lifted e-scooter and e-bike deliveries to 406,498, surpassing its own guidance. This surge across both four-wheel and two-wheel segments, combined with a global 2026 EV delivery goal of 300,000 units, highlights how VinFast is scaling an integrated electric ecosystem rather than relying on a single product line. Now we’ll examine how this record delivery performance, especially in e-scooters and...

Quarterly results and dividend announcement set fresh context for U.S. Physical Therapy U.S. Physical Therapy (USPH) reported first quarter 2026 revenue of US$198.29 million, compared with US$183.79 million a year earlier. Net income was US$5.04 million, versus US$9.9 million in the prior-year period, alongside a reaffirmed quarterly dividend. See our latest analysis for U.S. Physical Therapy. The earnings release appears to have reset expectations, with the stock’s 1 day share price return...

STAG Industrial (STAG) is back in focus after first quarter earnings showed higher revenue alongside lower net income and earnings per share, paired with steady leasing comments and a reaffirmed cash dividend. See our latest analysis for STAG Industrial. STAG Industrial’s US$38.67 share price reflects a modest 3.98% 1 month share price return and a 4.74% year to date share price return, while the 1 year total shareholder return of 18.62% points to momentum that has built over a longer stretch...

United Community Banks (UCB) is in focus after recent trading showed a mix of short term gains and pullbacks. This has prompted investors to reassess the stock’s valuation and performance across different time frames. See our latest analysis for United Community Banks. With the share price at US$33.56, recent trading has been choppy, with a 1-day share price return of a 1.12% decline contrasting with a 30-day share price return of 3.39%. The 1-year total shareholder return of 21.08% and...

Royalty Pharma plc recently reported first-quarter 2026 results showing revenue of US$631 million and net income of US$295 million, both higher than a year earlier, alongside continued share repurchases under its existing buyback program. Beyond the headline numbers, the company highlighted double-digit growth in recurring royalty receipts, increased its dividend, and committed over US$1.25 billion to new royalty and R&D funding deals, underscoring its role as a large-scale financier of...

Inhibrx Biosciences (INBX) has drawn fresh attention after scheduling a May 11 webcast to share interim Phase 2 HexAgon data on its OX40 agonist INBRX-106 in first-line head and neck cancer. See our latest analysis for Inhibrx Biosciences. The webcast follows a sharp 30 day share price return of about 100% and a year to date gain of nearly 66%. However, the 1 day share price return shows a 12% decline, while the 1 year total shareholder return is around 10x. If this kind of clinical catalyst...

Beyond Meat has recently reported first-quarter 2026 results, with net revenues of US$58.21 million versus US$68.73 million a year earlier, and a reduced net loss of US$28.48 million, while also completing follow-on equity offerings and filing a US$10.40 million shelf registration tied to employee stock plans. Alongside cost cuts and lower cash use, the company is pivoting beyond plant-based meat into functional food and beverages, including its new Beyond Immerse protein drink distributed...

PennyMac Financial Services (PFSI) drew fresh attention after first quarter 2026 results showed net income of US$82.32 million and higher earnings per share, alongside continued share buybacks and an affirmed quarterly dividend. See our latest analysis for PennyMac Financial Services. The stock has been under pressure, with a year to date share price return of negative 32.58% and a 1 year total shareholder return of negative 8.83%. However, the 3 year and 5 year total shareholder returns of...

Qorvo (QRVO) has jumped onto investor radars after reporting quarterly results that beat revenue and adjusted EPS expectations, and after completing a large share repurchase that reduced outstanding stock during the period. See our latest analysis for Qorvo. Qorvo's latest beat on revenue and adjusted EPS, alongside the completed buyback, comes after a 14.39% 1 month share price return. The 1 year total shareholder return of 22.94% contrasts with weaker multi year results, suggesting...

JBT Marel Corporation recently reported first-quarter 2026 results showing sales of US$936 million, a return to net income of US$45 million, and positive earnings per share from continuing operations, while reiterating full-year 2026 revenue and GAAP diluted EPS guidance. Alongside these financial updates, JBT Marel is pushing into the foodservice channel with its award-winning Fresh’n Squeeze 1800 Citrus Juicer, highlighting how its industrial processing expertise can be repurposed for...

In late April 2026, Tanger Inc. reported first-quarter results showing year-over-year increases in sales to US$143.54 million, revenue to US$150.42 million, and net income to US$28.26 million, while also completing a US$20.00 million repurchase of 589,622 shares and slightly raising its full-year diluted EPS guidance to US$1.05–US$1.13. Beyond the headline growth figures, the combination of higher quarterly earnings per share, an active buyback, and a guidance upgrade highlights Tanger’s...

Laureate Education, Inc. has reported past first-quarter 2026 results, with sales rising to US$272.61 million while its net loss widened to US$21.59 million, and the company has also issued second-quarter 2026 revenue guidance of US$597 million to US$601 million while reaffirming full-year expectations of about US$1.89 billion to US$1.91 billion. The combination of higher quarterly sales and reaffirmed full-year revenue guidance offers investors fresh information on how Laureate’s operations...

Guidance raise and first quarter earnings put Ventas in focus Ventas (VTR) raised its full year 2026 earnings guidance and reported first quarter results, highlighting higher property performance in its senior housing portfolio and contributions from recent investment activity. See our latest analysis for Ventas. After the guidance raise and first quarter results, Ventas’s recent share price moves tell a story of steady interest, with a 30 day share price return of 3.5%, year to date share...